EUVIMEDEUVIMED entdecken
Crossref

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid

Satoshi Shibuma, Jotaro On, Manabu Natsumeda, Akihide Koyama, Haruhiko Takahashi, Jun Watanabe, Masaki Mitobe, Satoshi Nakata, Yuki Tanaka, Yoshihiro Tsukamoto, Masayasu Okada, Junichi Yoshimura und 8 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Satoshi Shibuma und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Glioma, Biomarkers, Tumor, Histones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Sustainable Growth (NSG) group and Niigata University Brain Research Institute Collaborative Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Leptomeningeal disease (LMD) in diffuse midline gliomas (DMGs) can lead to devastating symptoms such as severe pain, urinary incontinence, and tetraparesis, with limited treatment options. We determined whether detecting H3F3A K27M‐mutant droplets in cerebrospinal fluid (CSF) circulating tumor deoxyribonucleic acid (ctDNA) could be a biomarker for detecting LMD in DMGs.

Methods

Twenty‐five CSF samples were obtained from 22 DMG patients. Histological confirmation of H3F3A K27M mutation was obtained in 10 (45.5%) cases. ctDNA was extracted from CSF, and H3F3A K27M‐mutant and wildtype droplets were detected using digital droplet polymerase chain reaction (ddPCR). LMD was diagnosed by CSF cytology and pre‐ and post‐contrast head and spine magnetic resonance (MR) imaging.

Results

The number of H3F3A K27M‐mutant droplets (median 27 [range: 1–379] vs. median 0 [range: 0–1]; p < 0.0001) and variant allele frequency (VAF) (median 48.9% [range: 7.5%–87.5%] vs. median 0.0% [range: 0.0%–50.0%]; p < 0.0001) were significantly higher in the LMD/early‐LMD group compared to no‐LMD group. In two cases (Cases 4 and 11) without clinical evidence of LMD, multiple H3F3A K27M‐mutant droplets were detected in CSF ctDNA. In those cases, extensive spinal dissemination was detected 6 months after the initial liquid biopsy. One case (Case 15) with high Schlafen11 (SLFN11) expression responded well to treatment for LMD and survived for 532 days after the diagnosis of LMD.

Conclusion

This study provides evidence that detecting H3F3A K27M‐mutant droplets in CSF ctDNA is diagnostic for LMD and is more sensitive than traditional methods such as CSF cytology and MR imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNAGliomaBiomarkers, TumorHistonesMutationMeningeal NeoplasmsBrain NeoplasmsHumansMaleFemaleChildChild, PreschoolAdolescentFollow-Up StudiesAdultPrognosisInfantYoung Adult

Stichwörter der Autor:innen

diffuse midline gliomadroplet digital PCRleptomeningeal diseaseliquid biopsy

Substanzen

Circulating Tumor DNABiomarkers, TumorHistonesH3-3A protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan.
  • Advanced Treatment of Neurological Diseases Branch, Brain Research Institute, Niigata University, Niigata, Japan.
  • Department of Legal Medicine, Graduate School of Medical and Dental Science, Niigata University, Niigata, Japan.
  • Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
  • Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Sustainable Growth (NSG) group and Niigata University Brain Research Institute Collaborative Project

Zitieren

APA

Shibuma, S., On, J., Natsumeda, M., Koyama, A., Takahashi, H., Watanabe, J., Mitobe, M., Nakata, S., Tanaka, Y., Tsukamoto, Y., Okada, M., Yoshimura, J., Tada, M., Shimizu, H., Oya, S., Murai, J., Okamoto, K., Kawashima, H., Kakita, A., & Oishi, M. (2025). Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31535

Vancouver

Shibuma S, On J, Natsumeda M, Koyama A, Takahashi H, Watanabe J, et al. Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31535

BibTeX
@article{Shibuma2025,
  author = {Shibuma, Satoshi and On, Jotaro and Natsumeda, Manabu and Koyama, Akihide and Takahashi, Haruhiko and Watanabe, Jun and Mitobe, Masaki and Nakata, Satoshi and Tanaka, Yuki and Tsukamoto, Yoshihiro and Okada, Masayasu and Yoshimura, Junichi and Tada, Mari and Shimizu, Hiroshi and Oya, Soichi and Murai, Junko and Okamoto, Kouichirou and Kawashima, Hiroyuki and Kakita, Akiyoshi and Oishi, Makoto},
  title = {Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31535}
}
Kostenlos starten →